Inmune Bio (INMB) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for Inmune Bio (INMB) over the last 8 years, with Q2 2025 value amounting to $81000.0.
- Inmune Bio's Change in Account Payables fell 240.96% to $81000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $45000.0, marking a year-over-year decrease of 2622.95%. This contributed to the annual value of -$10000.0 for FY2024, which is 13846.15% down from last year.
- As of Q2 2025, Inmune Bio's Change in Account Payables stood at $81000.0, which was down 240.96% from $78000.0 recorded in Q1 2025.
- In the past 5 years, Inmune Bio's Change in Account Payables registered a high of $83000.0 during Q2 2024, and its lowest value of -$84000.0 during Q3 2024.
- Over the past 5 years, Inmune Bio's median Change in Account Payables value was $0.0 (recorded in 2021), while the average stood at $5714.3.
- In the last 5 years, Inmune Bio's Change in Account Payables crashed by 450000.0% in 2023 and then surged by 27142.86% in 2025.
- Over the past 5 years, Inmune Bio's Change in Account Payables (Quarter) stood at $70000.0 in 2021, then crashed by 98.57% to $1000.0 in 2022, then plummeted by 4500.0% to -$44000.0 in 2023, then surged by 31.82% to -$30000.0 in 2024, then skyrocketed by 370.0% to $81000.0 in 2025.
- Its Change in Account Payables stands at $81000.0 for Q2 2025, versus $78000.0 for Q1 2025 and -$30000.0 for Q4 2024.